𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro chemosensitivity testing in the treatment of ovarian carcinoma

✍ Scribed by H. Auner; E. Petru; H. M. H. Hofmann; H. Pickel; P. Pürstner

Publisher
Springer
Year
1989
Tongue
English
Weight
293 KB
Volume
246
Category
Article
ISSN
0003-9128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Involvement of aminopeptidase N in enhan
Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo
✍ Mamoru Yamashita; Hiroaki Kajiyama; Mikio Terauchi; Kiyosumi Shibata; Kazuhiko I 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 428 KB

## Abstract Aminopeptidase N (APN/CD13), a 150‐kDa metalloproteinase, is a multifunctional cell surface aminopeptidase with ubiquitous expression. Recent studies have suggested that APN/CD13 plays an important role in tumor progression in several human malignancies. In the current study, we investi

Overexpression of BclXL in a human ovari
Overexpression of BclXL in a human ovarian carcinoma cell line: Paradoxic effects on chemosensitivity in vitro versus in vivo
✍ Paul M. Rogers; Philip J. Beale; Mansour Al-Moundhri; Frances Boxall; Lisa Patte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 238 KB

## Abstract The effect of overexpressing the antiapoptotic protein Bcl~XL~ in a human ovarian carcinoma cell line has been investigated in terms of sensitivity to the 2 major drugs used to treat this disease, paclitaxel and cisplatin. Stable transfection of __Bcl__~__XL__~ into CH1 cells, which are

Clonogenic assay and in vitro chemosensi
Clonogenic assay and in vitro chemosensitivity testing of human urologic malignancies
✍ Michael F. Sarosdy; Donald L. Lamm; Howard M. Radwin; Daniel D. Von Hoff 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 796 KB

Over the past year, we have attempted to grow both primary and metastatic urologic malignancies using a recently developed human tumor cloning system. Formation of colonies in vitro occurred in 125 of 164 primary tumors (76%), including 34 of 47 uroepithelial cancer specimens, 45 of 50 renal cell ca

Adjuvant 32P in the treatment of ovarian
Adjuvant 32P in the treatment of ovarian carcinoma
✍ Kellie S. Condra; William M. Mendenhall; Linda S. Morgan; Robert B. Marcus Jr. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

The purpose of this study was to evaluate the efficacy of adjuvant 32 P for patients with high-risk, early-stage ovarian carcinoma. Twenty-five patients underwent apparent complete resection followed by 32 P (15 mCi) at the University of Florida between 1976 and 1993. Minimum and median follow-up ti